07/31/2026
Congratulations to the entire team at Rigel Pharmaceuticals on the approval of VEPPANU™ (vepdegestrant). As a pharmacy partner, we are committed to delivering personalized clinical support and compassionate care throughout every stage of the patient journey in support of patients living with breast cancer.
Press Release: https://ow.ly/oNSF50Zv0NB